IFNG and respiratory syncytial virus infectious disease: Furthermore, IL-13 has been shown to significantly modulate respiratory syncytial virus infection, including decreasing the viral titers, inhibiting the lung IFN-γ production, and reducing weight loss, as well as affecting viral entry, replication, and cell-to-cell transmission (45).